Venenum Biodesign
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Black Forest Rd, Hamilton, New Jersey,...Phone Number
(609) 587-1827Website
www.venenumbiodesign.comRevenue
$7.2 MillionIndustry
About Venenum Biodesign
VENENUM, a member of Genesis Biotechnology Group, is a drug discovery company dedicated to identifying new drug targets and developing innovative medicines for various diseases. The company focuses on advancing its products through clinical and commercial partnerships to bring them to patients. With a robust pipeline and a large collection of small molecules, VENENUM offers a range of services including assay development, structural biology, and custom synthesis. Their intended clients include pharmaceutical companies and research organizations involved in drug discovery and development.Explore more
Venenum Biodesign Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Venenum Biodesign
Compare insights from companies similar to Venenum Biodesign, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Venenum Biodesign Tech Stack
A closer look at the technologies used by Venenum Biodesign
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Venenum Biodesign
Sign Up For FreeTo access detailed company insights
VENENUM, a member of Genesis Biotechnology Group, is a drug discovery company dedicated to identifying new drug targets and developing innovative medicines for various diseases. The company focuses on advancing its products through clinical and commercial partnerships to bring them to patients. With a robust pipeline and a large collection of small... Read More
